Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AIM ImmunoTech Inc. | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - AIM ImmunoTech Inc. | exhibit322-20141.htm |
| EX-21 - EXHIBIT 21 - AIM ImmunoTech Inc. | exhibit21-20141.htm |
| EX-31.1 - EXHIBIT 31.1 - AIM ImmunoTech Inc. | exhibit311-20141.htm |
| EX-31.2 - EXHIBIT 31.2 - AIM ImmunoTech Inc. | exhibit312-20141.htm |
| EX-32.1 - EXHIBIT 32.1 - AIM ImmunoTech Inc. | exhibit321-20141.htm |
| EX-23.1 - EXHIBIT 23.1 - AIM ImmunoTech Inc. | exhibit231-20141.htm |
| EX-10.25 - EXHIBIT 10.25 - AIM ImmunoTech Inc. | a1025-emergehemispherxagre.htm |
| XML - IDEA: XBRL DOCUMENT - AIM ImmunoTech Inc. | R9999.htm |
| 10-K - 10-K - AIM ImmunoTech Inc. | heb1231201410k.htm |
ARMADA
Health Care
August 8, 2014
Dr. William A. Carter Chairman and CEO Hemispherx Biopharma, Inc.
JFK Boulevard
Suite 500
Philadelphia, Pa 19103
Re: Agreements Between Armada Health Care, LLC and Hemispherx Biopharma, Inc. and
BioRidge Pharma and Hemispherx Biopharma, Inc.
Dear Dr. Carter,
Armada Health Care and BioRidge Pharma would like to request an extension to the above mentioned contracts initially signed on August 15, 2011 and extended in 2012 and 2013 through August 14, 2014 subject to the same terms and conditions currently in place.
Please sign this acceptance letter as acknowledgment of the extension through August 14, 2015 and return to my attention via fax or e-mail. I can be reached at 973-564-8004 if you have any questions
or concerns.
Regards,
Ryan Oligino
Vice President
Armada Health Care
Phone: 973-564-8004
Fax: 973-564-8010
/S/: William A. Carter | |
(signature) | |
William A. Cartrer | |
(print name) | |
CEO and Chairman | |
(Title) | |
8/9/2014 | |
(Date) | |